Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

NCT06876571 is registered in ClinicalTrials.gov with Invivoscribe, Inc. as lead sponsor.

NCT NCT06876571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06876571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay
Lead sponsor
Invivoscribe, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
June 2, 2025
Completion date
December 6, 2025
Enrollment
250 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

t-cell lymphoproliferative disorder